These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 2975612

  • 21. What are the approaches for evaluating antihypertensive treatment by 24 h ambulatory blood pressure monitoring?
    Neutel JM, Smith DH, Weber MA.
    Blood Press Monit; 1999; 4 Suppl 2():S23-8. PubMed ID: 10822419
    [Abstract] [Full Text] [Related]

  • 22. Comparative effects of felodipine ER, amlodipine and nifedipine GITS on 24 h blood pressure control and trough to peak ratios in mild to moderate ambulatory hypertension: a forced titration study.
    Lefebvre J, Poirier L, Archambault F, Jewell D, Reed CV, Lacourcière Y.
    Can J Cardiol; 1998 May; 14(5):682-8. PubMed ID: 9627524
    [Abstract] [Full Text] [Related]

  • 23. Angiotensin converting enzyme inhibition decreases systolic blood pressure more than diastolic pressure as shown by ambulatory blood pressure monitoring.
    Asmar RG, Pannier BM, Santoni JP, Safar ME.
    J Hypertens Suppl; 1988 Dec; 6(3):S79-81. PubMed ID: 3225692
    [Abstract] [Full Text] [Related]

  • 24. Comparison of amlodipine and captopril in hypertension based on 24-hour ambulatory monitoring.
    Lacourcière Y, Poirier L, Provencher P.
    J Cardiovasc Pharmacol; 1993 Dec; 22 Suppl A():S20-3. PubMed ID: 7522283
    [Abstract] [Full Text] [Related]

  • 25. [Comparative study of bisoprolol and celiprolol in to moderate hypertension using casual as well as ambulatory blood pressure measurements].
    Marquand A, Prost PL, Grippat JC.
    Ann Cardiol Angeiol (Paris); 1994 May; 43(5):301-6. PubMed ID: 8074426
    [Abstract] [Full Text] [Related]

  • 26. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
    Qiu YG, Yao XY, Tao QM, Zheng P, Chen JZ, Zhu JH, Zhang FR, Zheng LR, Zhao LL.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
    [Abstract] [Full Text] [Related]

  • 27. Daytime-selective antihypertensive activity of celiprolol.
    Cleophas TJ, van der Meulen J, van de Luit L, Zwinderman AH.
    Angiology; 1999 Oct; 50(10):797-803. PubMed ID: 10535718
    [Abstract] [Full Text] [Related]

  • 28. Effects of celiprolol on cardiovascular reactivity to laboratory stressors in patients with hypertension.
    Cardillo C, Degen C, De Felice F, Folli G.
    Clin Pharmacol Ther; 1992 May; 51(5):555-61. PubMed ID: 1534042
    [Abstract] [Full Text] [Related]

  • 29. Celiprolol in systemic hypertension.
    Frishman WH, Flamenbaum W, Schoenberger J, Schwartz GL, Vidt DG, Neri GS, Greenberg S, Lazar E, Godfrey JC, Stevenson A.
    Am J Cardiol; 1989 Apr 01; 63(12):839-42. PubMed ID: 2522723
    [Abstract] [Full Text] [Related]

  • 30. Ambulatory blood pressure monitoring in the assessment of antihypertensive treatment: 24-h blood pressure control with lacidipine once a day.
    Palatini P, Penzo M, Guzzardi G, Anaclerio M, Pessina AC.
    J Hypertens Suppl; 1991 Dec 01; 9(3):S61-6. PubMed ID: 1798003
    [Abstract] [Full Text] [Related]

  • 31. A multi-centre, placebo controlled comparative study between 200 mg and 400 mg celiprolol in patients with mild to moderate essential hypertension.
    Trafford JA, Latta D, Little PS, Parsley J, Ankier SI, Quail D.
    Curr Med Res Opin; 1989 Dec 01; 11(9):550-6. PubMed ID: 2533057
    [Abstract] [Full Text] [Related]

  • 32. Systemic and renal hemodynamic effects of celiprolol in essential hypertensives.
    Lucarini AR, Salvetti A.
    Am J Cardiol; 1988 Feb 10; 61(5):45C-48C. PubMed ID: 2963525
    [Abstract] [Full Text] [Related]

  • 33. [Treatment of hypertension with a new beta blocker-diuretic combination under long-term control].
    Hoffmann H, Hoffmann W.
    Wien Med Wochenschr; 1985 Mar 15; 135(5):127-34. PubMed ID: 2859703
    [Abstract] [Full Text] [Related]

  • 34. Balanced 24-hour blood pressure control by angiotensin-converting enzyme inhibitors administered once daily.
    Parati G, Ravogli A, Trazzi S, Omboni S, Frattola A, Lattuada S, Libretti A, Mancia G.
    J Hum Hypertens; 1989 Jun 15; 3 Suppl 1():3-9. PubMed ID: 2674440
    [Abstract] [Full Text] [Related]

  • 35. [The results of a celiprolol drug surveillance study in Spain. The Celiprolol Multicenter Group].
    An Med Interna; 1989 Dec 15; 6(12):619-23. PubMed ID: 2535249
    [Abstract] [Full Text] [Related]

  • 36. Comparison of the antihypertensive effects of celiprolol and acebutolol.
    Terziivanov D, Vlahov V, Belovezhdov N, Gerova Z.
    Eur J Clin Pharmacol; 1988 Dec 15; 34(2):125-8. PubMed ID: 2968268
    [Abstract] [Full Text] [Related]

  • 37. [Results of the selectol field study in Austria].
    Hoffman W, Hoffman H.
    Wien Med Wochenschr Suppl; 1985 Dec 15; 93():1-12. PubMed ID: 2932860
    [Abstract] [Full Text] [Related]

  • 38. [Evaluation of the 24-hour effect of a once-daily antihypertensive drug on the diurnal blood pressure profile].
    Abetel G, Karly M, Soret P.
    Schweiz Med Wochenschr; 1990 Dec 08; 120(49):1890-3. PubMed ID: 2148223
    [Abstract] [Full Text] [Related]

  • 39. [Beta blockade with celiprolol in tardive dyskinesia patients treated with neuroleptics].
    Hebenstreit GF, Hoffmann H, Hoffmann W, Pittner H.
    Wien Klin Wochenschr; 1986 Jun 13; 98(12):388-92. PubMed ID: 2874663
    [Abstract] [Full Text] [Related]

  • 40. [Clinical studies of celiprolol in the treatment of arterial hypertension].
    Belovezhdov N, Nachev Ch, Angelova I, Gergova V, Stefanov G.
    Vutr Boles; 1985 Jun 13; 24(5):74-7. PubMed ID: 2868573
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.